INSIDER INFORMATION STOCKHOLM, Jan. 22, 2024 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR) (“Medivir” or the “Company”), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that the board of directors…